MARKET

GILD

GILD

Gilead Sciences Inc
NASDAQ
103.63
+2.23
+2.20%
After Hours: 103.63 0 0.00% 16:40 04/11 EDT
OPEN
102.18
PREV CLOSE
101.40
HIGH
104.79
LOW
100.76
VOLUME
8.68M
TURNOVER
--
52 WEEK HIGH
119.12
52 WEEK LOW
59.82
MARKET CAP
129.19B
P/E (TTM)
270.93
1D
5D
1M
3M
1Y
5Y
1D
Validea Detailed Fundamental Analysis - GILD
NASDAQ · 7h ago
Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Argenx Se (ARGX) and COMPASS Pathways (CMPS)
TipRanks · 9h ago
How to Play the Biotech Meltdown in the Age of RFK Jr. and Tariffs -- Heard on the Street
The Wall Street Journal · 11h ago
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies
Benzinga · 12h ago
GILEAD: FOR Q1, EXPECTS $253.4M IN ACQUIRED IPR&D EXPENSES
Reuters · 1d ago
GILEAD: FOR Q1 , EXPECTS CHARGE OF ABOUT $0.16 TO BOTH GAAP AND NON-GAAP EPS, IN ACQUIRED IPR&D EXPENSES
Reuters · 1d ago
GILEAD SCIENCES TO RELEASE FIRST QUARTER 2025 FINANCIAL RESULTS ON THURSDAY, APRIL 24, 2025
Reuters · 1d ago
Ideaya Biosciences initiates expansion in IDE397 trial
TipRanks · 1d ago
More
About GILD
More
Gilead Sciences, Inc. is a biopharmaceutical company. The Company is engaged in advancing medicines to prevent and treat life-threatening diseases, including human immunodeficiency virus (HIV), viral hepatitis, COVID-19, cancer and inflammation. It is focused on discovering, developing and delivering medicines to address unmet medical needs in virology, oncology and other therapeutic areas. Its portfolio of marketed products includes Biktarvy, Genvoya, Descovy, Complera/Eviplera, Symtuza, Truvada, Stribild, Sunlenca, Epclusa, Vemlidy, Harvoni, Viread, Livdelzi, Veklury, Yescarta, Tecartus, Trodelvy, AmBisome, and Letairis. Its product candidates include Bulevirtide, Lenacapavir, Axicabtagene ciloleucel, Anitocabtagene autoleucel, Sacituzumab govitecan-hziy, and Domvanalimab and zimberelimab. Biktarvy is an oral formulation dosed once a day for the treatment of HIV-1 infection in certain patients. It operates in more than 35 countries worldwide.
Recently
Symbol
Price
%Change

Webull offers Gilead Sciences Inc stock information, including NASDAQ: GILD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GILD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GILD stock methods without spending real money on the virtual paper trading platform.